When surgery is too risky and medical management has failed, MitraClip offers those who suffer from mitral regurgitation an advanced minimally invasive treatment option that gets results.
- MitraClip is approved to treat patients with secondary, or functional, mitral regurgitation whose symptoms continue following medical therapy.
- Delivered by a catheter, the MitraClip attaches to the mitral valve and enables it to close more completely, helping to restore normal blood flow.
- MitraClip is included in the new medical guidelines for treating mitral regurgitation.
- Results have shown decreased hospitalizations for heart failure and mortality after MitraClip therapy.